- Home
- ABVX vs RERE Comparison
ABVX vs RERE Comparison
Compare ABVX & RERE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABVX
- RERE
- Stock Information
- Founded
- ABVX 2013
- RERE 2011
- Country
- ABVX France
- RERE China
- Employees
- ABVX N/A
- RERE N/A
- Industry
- ABVX
- RERE Other Specialty Stores
- Sector
- ABVX
- RERE Consumer Discretionary
- Exchange
- ABVX Nasdaq
- RERE Nasdaq
- Market Cap
- ABVX 511.3M
- RERE 444.1M
- IPO Year
- ABVX N/A
- RERE 2021
- Fundamental
- Price
- ABVX $7.90
- RERE $3.48
- Analyst Decision
- ABVX Buy
- RERE
- Analyst Count
- ABVX 4
- RERE 0
- Target Price
- ABVX $31.50
- RERE N/A
- AVG Volume (30 Days)
- ABVX 254.8K
- RERE 1.3M
- Earning Date
- ABVX 08-11-2025
- RERE 08-19-2025
- Dividend Yield
- ABVX N/A
- RERE N/A
- EPS Growth
- ABVX N/A
- RERE N/A
- EPS
- ABVX N/A
- RERE 0.07
- Revenue
- ABVX $11,444,012.00
- RERE $2,388,301,386.00
- Revenue This Year
- ABVX $284.20
- RERE $27.37
- Revenue Next Year
- ABVX N/A
- RERE $24.06
- P/E Ratio
- ABVX N/A
- RERE $48.45
- Revenue Growth
- ABVX 128.98
- RERE 26.09
- 52 Week Low
- ABVX $4.77
- RERE $2.00
- 52 Week High
- ABVX $14.16
- RERE $3.70
- Technical
- Relative Strength Index (RSI)
- ABVX 65.58
- RERE 69.81
- Support Level
- ABVX $7.41
- RERE $3.25
- Resistance Level
- ABVX $8.13
- RERE $3.53
- Average True Range (ATR)
- ABVX 0.43
- RERE 0.19
- MACD
- ABVX 0.12
- RERE 0.06
- Stochastic Oscillator
- ABVX 92.21
- RERE 90.81
About ABVX Abivax SA American
Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.
About RERE ATRenew Inc.
ATRenew Inc is a pre-owned consumer electronics transactions and services platform in China. The majority of its revenue is derived from online product sales of phones and other consumer electronics goods through its platform. The Company's principal operations and geographic markets are in the People's Republic of China.